公开(公告)号：US20230138901A1

公开(公告)日：2023-05-04

申请号：US17788415

申请日：2020-12-24

申请人： HANGZHOU ZHONGMEIHUADONG PHARMACEUTICAL CO., LTD.

发明人： Zhixiang PAN ,  Haiying HE ,  Zhigan JIANG ,  Jianhua XIA ,  Lei ZHANG ,  Chen ZHANG ,  Jian LI ,  Shuhui CHEN

IPC分类号： C07D495/04 ,  C07D403/04 ,  C07D513/04 ,  A61P3/08

摘要： A compound having a KHK inhibitory effect, or pharmaceutically acceptable salts thereof, and use thereof in the preparation of a medicament for treating a disease associated with KHK kinase abnormal expression. Provided is a compound as represented by formula (III) or a pharmaceutically acceptable salt thereof.